[Biotransformation of amiodaquine and prophylaxis of Plasmodium falciparum malaria].
The authors have devised a specific HPLC method for amodiaquine assay which demonstrated that the drug disappeared rapidly from the blood of subjects under prophylaxis for malaria (10 mg/kg/week in a single oral dose). The main metabolite was identified as the monodesethyl derivative which is the only active form of the drug. The low erythrocytic levels of the metabolite, observed at day +7, might account for the failure in the prophylaxis of P. falciparum malaria with amodiaquine in a few cases. The in vitro activity of monodesethyl amodiaquine should be evaluated during the chemosensitivity tests and the chemoprophylaxis schedule, re-evaluated.
D000655:Amodiaquine / Q000097:blood* / Q000627:therapeutic use; D000818:Animals; D001711:Biotransformation; D002851:Chromatography, High Pressure Liquid; D004912:Erythrocytes / Q000378:metabolism; D005260:Female; D006801:Humans; D007700:Kinetics; D008288:Malaria / Q000517:prevention & control*; D008297:Male; D008657:Metabolic Clearance Rate; D010963:Plasmodium falciparum
D000655:Amodiaquine
Biotransformation de l'amodiaquine et prophylaxie du paludisme à Plasmodium falciparum.